ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 76 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 27.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | -27.0% | 48,615 | -51.7% | 0.00% | – |
| Q2 2022 | $100,000 | +25.0% | 100,644 | +637.3% | 0.00% | – |
| Q3 2021 | $80,000 | -32.2% | 13,650 | -6.5% | 0.00% | – |
| Q2 2021 | $118,000 | -15.1% | 14,600 | -12.6% | 0.00% | – |
| Q1 2021 | $139,000 | -73.8% | 16,700 | -76.1% | 0.00% | – |
| Q4 2020 | $530,000 | -59.4% | 69,892 | -18.9% | 0.00% | -100.0% |
| Q2 2020 | $1,306,000 | -6.2% | 86,179 | +30.1% | 0.00% | -50.0% |
| Q1 2019 | $1,392,000 | +92.5% | 66,264 | +5.4% | 0.00% | 0.0% |
| Q4 2018 | $723,000 | -81.4% | 62,898 | -57.5% | 0.00% | -81.8% |
| Q4 2017 | $3,881,000 | +89.0% | 148,135 | +62.0% | 0.01% | +57.1% |
| Q3 2017 | $2,053,000 | -34.2% | 91,446 | -23.8% | 0.01% | -82.5% |
| Q2 2014 | $3,121,000 | +755.1% | 120,038 | +616.7% | 0.04% | +900.0% |
| Q1 2014 | $365,000 | – | 16,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $36,906,000 | 26.83% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,213,152 | $71,202,000 | 13.37% |
| Selkirk Management LLC | 697,610 | $11,790,000 | 3.21% |
| GRIFFIN ASSET MANAGEMENT, INC. | 994,657 | $16,810,000 | 2.36% |
| Chicago Capital, LLC | 1,314,093 | $22,208,000 | 1.36% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $2,620,000 | 0.69% |
| CHARTIST INC /CA/ | 64,765 | $1,094,529,000 | 0.67% |
| Cannell & Co. | 1,095,439 | $18,513,000 | 0.66% |
| Trellus Management Company, LLC | 22,500 | $380,000 | 0.64% |
| Belpointe Asset Management LLC | 271,514 | $4,589,000 | 0.58% |